NL8203225A - Carbostyrilderivaten, werkwijzen ter bereiding ervan, alsmede farmaceutische preparaten die deze derivaten bevatten. - Google Patents

Carbostyrilderivaten, werkwijzen ter bereiding ervan, alsmede farmaceutische preparaten die deze derivaten bevatten. Download PDF

Info

Publication number
NL8203225A
NL8203225A NL8203225A NL8203225A NL8203225A NL 8203225 A NL8203225 A NL 8203225A NL 8203225 A NL8203225 A NL 8203225A NL 8203225 A NL8203225 A NL 8203225A NL 8203225 A NL8203225 A NL 8203225A
Authority
NL
Netherlands
Prior art keywords
group
carbostyril
general formula
contain
phenyl ring
Prior art date
Application number
NL8203225A
Other languages
English (en)
Dutch (nl)
Original Assignee
Otsuka Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP56137984A external-priority patent/JPS5838258A/ja
Priority claimed from JP56210368A external-priority patent/JPS58110568A/ja
Application filed by Otsuka Pharma Co Ltd filed Critical Otsuka Pharma Co Ltd
Publication of NL8203225A publication Critical patent/NL8203225A/nl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20Oxygen atoms
    • C07D215/22Oxygen atoms attached in position 2 or 4
    • C07D215/227Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Quinoline Compounds (AREA)
NL8203225A 1981-09-01 1982-08-17 Carbostyrilderivaten, werkwijzen ter bereiding ervan, alsmede farmaceutische preparaten die deze derivaten bevatten. NL8203225A (nl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP13798481 1981-09-01
JP56137984A JPS5838258A (ja) 1981-09-01 1981-09-01 カルボスチリル誘導体
JP56210368A JPS58110568A (ja) 1981-12-25 1981-12-25 カルボスチリル誘導体
JP21036881 1981-12-25

Publications (1)

Publication Number Publication Date
NL8203225A true NL8203225A (nl) 1983-04-05

Family

ID=26471144

Family Applications (1)

Application Number Title Priority Date Filing Date
NL8203225A NL8203225A (nl) 1981-09-01 1982-08-17 Carbostyrilderivaten, werkwijzen ter bereiding ervan, alsmede farmaceutische preparaten die deze derivaten bevatten.

Country Status (21)

Country Link
US (1) US4514401A (de)
KR (1) KR860000135B1 (de)
AR (2) AR241905A1 (de)
AT (1) AT383592B (de)
AU (1) AU532361B2 (de)
BE (1) BE894105A (de)
CA (1) CA1205807A (de)
CH (1) CH650783A5 (de)
DE (1) DE3230209C2 (de)
DK (1) DK166877B1 (de)
ES (5) ES8401058A1 (de)
FI (1) FI78688C (de)
FR (1) FR2512019B1 (de)
GB (1) GB2108109B (de)
IT (1) IT1156490B (de)
NL (1) NL8203225A (de)
NO (1) NO159591C (de)
PH (1) PH18055A (de)
PT (1) PT75424B (de)
SE (1) SE452984B (de)
SU (1) SU1356962A3 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH17194A (en) * 1980-03-06 1984-06-19 Otsuka Pharma Co Ltd Novel carbostyril derivatives,and pharmaceutical composition containing the same
FR2557570B1 (fr) * 1984-01-04 1986-04-18 Adir Nouveaux derives de la quinoleine, leur procede de preparation et les compositions pharmaceutiques les renfermant
DE3423003A1 (de) * 1984-06-22 1986-01-02 Beiersdorf Ag, 2000 Hamburg Benzo(c)(1,8)naphthyridine, verfahren zu ihrer herstellung und ihre verwendung sowie diese verbindungen enthaltende zubereitungen
DE3431303A1 (de) * 1984-08-25 1986-02-27 Goedecke Ag 1,6-naphthyridin-derivate, verfahren zu deren herstellung und deren verwendung
US4886809A (en) * 1986-07-31 1989-12-12 Otsuka Pharmaceutical Co., Ltd. Carbostyril derivatives and salts thereof
JPH0696555B2 (ja) * 1986-07-31 1994-11-30 大塚製薬株式会社 カルボスチリル誘導体
US5098477A (en) * 1988-12-14 1992-03-24 Ciba-Geigy Corporation Inks, particularly for ink printing
JP2686887B2 (ja) * 1992-08-11 1997-12-08 キッセイ薬品工業株式会社 ピペリジノ−3,4−ジヒドロカルボスチリル誘導体
NZ547278A (en) * 2003-12-10 2010-01-29 Janssen Pharmaceutica Nv Substituted 6-cyclohexylalkyl substituted 2-quinolinones and 2-quinoxalinones as PARP inhibitors for chemosensitization or radiosensitization
HRP20171415T4 (hr) 2009-06-25 2023-03-03 Alkermes Pharma Ireland Limited Heterociklični spojevi za liječenje neuroloških i psiholoških poremećaja
ES2834973T3 (es) 2010-05-04 2021-06-21 Alkermes Pharma Ireland Ltd Procedimiento de síntesis de compuestos de lactama oxidada
RU2448698C2 (ru) * 2010-06-21 2012-04-27 Государственное образовательное учреждение высшего профессионального образования "Нижегородская государственная медицинская академия Федерального Агентства по здравоохранению и социальному развитию" (ГОУ ВПО НижГМА Росздрава) Способ восстановления синусового ритма при трепетании предсердий i типа
EP2585066B1 (de) 2010-06-24 2018-09-26 Alkermes Pharma Ireland Limited Prodrugs aus nh-säureverbindungen: ester-, carbonat-, carbamat- und phosphonat-derivate

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5118771A (ja) * 1974-08-07 1976-02-14 Akimitsu Takeya Bantaioshigatanitaisuru keshoshiitotenchakuho
US4081447A (en) * 1975-04-09 1978-03-28 Abbott Laboratories 5-[2-Hydroxy-3-(3,4-dimethoxy phenethylamino)]-propoxy-3,4-dihydro carbostyril and pharmaceutically acceptable salts thereof
JPS597707B2 (ja) * 1975-06-23 1984-02-20 オオツカセイヤク カブシキガイシヤ カルボスチリルユウドウタイノ セイゾウホウ
JPS52283A (en) * 1975-06-23 1977-01-05 Otsuka Pharmaceut Co Ltd Process for preparation of carbostyril derivatives
GB1589871A (en) * 1976-07-19 1981-05-20 Conder Group Serv Ltd Tank construction
JPS5416478A (en) * 1977-07-08 1979-02-07 Otsuka Pharmaceut Co Ltd 3,4-dihydrocarbostyril herivative
DE2853996A1 (de) * 1978-12-14 1980-07-03 Hoechst Ag Neue substituierte phenylpiperazinderivate und verfahren zu deren herstellung
JPS5585520A (en) * 1978-12-22 1980-06-27 Otsuka Pharmaceut Co Ltd Remedy for peptic ulcer
DE2928583A1 (de) * 1979-07-14 1981-01-29 Thomae Gmbh Dr K Verfahren zur herstellung von carbostyrilderivaten
PH17194A (en) * 1980-03-06 1984-06-19 Otsuka Pharma Co Ltd Novel carbostyril derivatives,and pharmaceutical composition containing the same
FI77852C (fi) * 1981-02-17 1989-05-10 Otsuka Pharma Co Ltd Foerfarande foer framstaellning av nya, saosom hjaertmediciner anvaendbara substituerade amid- och (maettad heterocykel)karbonylkarbostyrilderivat.

Also Published As

Publication number Publication date
GB2108109B (en) 1985-05-09
PT75424A (en) 1982-09-01
AR241905A1 (es) 1993-01-29
SE8204677L (sv) 1983-03-02
DE3230209C2 (de) 1985-08-22
FI822803A0 (fi) 1982-08-11
SE8204677D0 (sv) 1982-08-13
DK166877B1 (da) 1993-07-26
ES521473A0 (es) 1984-05-16
AR240918A2 (es) 1991-03-27
ES521472A0 (es) 1984-05-16
ES8405001A1 (es) 1984-05-16
KR840001157A (ko) 1984-03-28
ES8500933A1 (es) 1984-11-01
PH18055A (en) 1985-03-18
US4514401A (en) 1985-04-30
IT1156490B (it) 1987-02-04
SE452984B (sv) 1988-01-04
BE894105A (fr) 1983-02-14
FR2512019B1 (fr) 1986-01-03
IT8268020A0 (it) 1982-08-16
AU532361B2 (en) 1983-09-29
ES536982A0 (es) 1985-07-01
FR2512019A1 (fr) 1983-03-04
AT383592B (de) 1987-07-27
DK361982A (da) 1983-03-02
FI78688C (fi) 1989-09-11
SU1356962A3 (ru) 1987-11-30
KR860000135B1 (ko) 1986-02-26
ES8506302A1 (es) 1985-07-01
NO159591B (no) 1988-10-10
AR240918A1 (es) 1991-03-27
ES521471A0 (es) 1984-11-01
ES514992A0 (es) 1983-11-16
PT75424B (en) 1985-01-04
ES8405000A1 (es) 1984-05-16
AU8698082A (en) 1983-04-14
CA1205807A (en) 1986-06-10
NO159591C (no) 1989-01-18
ES8401058A1 (es) 1983-11-16
DE3230209A1 (de) 1983-03-10
ATA310682A (de) 1986-12-15
NO822749L (no) 1983-03-02
FI822803L (fi) 1983-03-02
CH650783A5 (de) 1985-08-15
GB2108109A (en) 1983-05-11
FI78688B (fi) 1989-05-31

Similar Documents

Publication Publication Date Title
KR0138529B1 (ko) 카르보스티릴 유도체
NL8203225A (nl) Carbostyrilderivaten, werkwijzen ter bereiding ervan, alsmede farmaceutische preparaten die deze derivaten bevatten.
KR101749232B1 (ko) 에이즈 치료에 유용한 화합물
DE69434020T2 (de) Verfahren und zwischenprodukte für die herstellung von 5-[4-(benzisothiazol-3-yl)-piperazin-1-yl)ethyl]-6 chlor-1,3-dihydro-indol-2-one
SK1582003A3 (en) Benzimidazole derivatives, preparation and therapeutic use thereof
JP2008501732A (ja) Ccr5拮抗剤としての化合物
JPH01503233A (ja) 製薬活性化合物
JPH01265100A (ja) 2―置換アデノシン誘導体
EP0145010B1 (de) Carbostyrilderivate
JPS6344572A (ja) 抗不整脈剤
US4874773A (en) 3-Aminocarbonyl-1,4-dihydropyridine-5-carboxylic acid compounds, and pharmaceutical composition containing the same
CS196357B2 (en) Process for preparing new basic substituted derivatives of xanthine
EP0168003B1 (de) Oxindolverbindungen, diese enthaltende Zusammensetzungen sowie Verfahren zur Herstellung derselben
JPH0441149B2 (de)
AU2018332634A1 (en) Compounds useful as inhibitors of isoprenylcysteine carboxyl methyltransferase
DK145949B (da) Analogifremgangsmaade til fremstilling af i 3-stillingen substituerede rifamycin s-forbindelser eller sv-forbindelser ellersyreadditionssalte eller kvaternaere ammoniumsalte deraf
JP2544488B2 (ja) 3’―ヒドロキシベンゾキサジノリファマイシン誘導体
HUT63160A (en) Process for producing tetrahydrocarbazole derivatives of dihydropyridines and pharmaceutical compositions comprising same
US4766124A (en) Beta-carbolin H1-receptor antagonists
JP2023062631A (ja) 化合物又はその塩並びに医薬組成物及び抗hiv剤
JPS58110568A (ja) カルボスチリル誘導体
JPH03258763A (ja) スルホンアミド誘導体及びそれを含有する医薬組成物
JPH05105631A (ja) 抗痴呆薬
JPH04230688A (ja) アシル誘導体
JPH0249769A (ja) カルボスチリル誘導体

Legal Events

Date Code Title Description
A85 Still pending on 85-01-01
BA A request for search or an international-type search has been filed
BB A search report has been drawn up
BC A request for examination has been filed
BV The patent application has lapsed